SOLARINDS - Solar Industries India Limited Share Price

Management of Solar Industries India Limited provided an optimistic outlook for FY '27, targeting total revenue of INR 14,000 crores, with a strong order book of INR 21,300 crores. They aim to maintain EBITDA margins around 27-28%. The domestic and international businesses will contribute to this growth, with a projected 35% increase in domestic revenue, excluding defense.

Key forward-looking points include:

1. Defense Business Growth: Anticipated defense revenue to exceed INR 4,500 crores for FY '27, with a 134% growth in Q4 FY '26, reaching INR 1,008 crores.
2. International Business Expansion: 32% growth year-on-year, with particular focus on African markets and planned operations in countries like Zambia, Tanzania, Zimbabwe, and Ghana. The company also plans to enhance its presence in Southeast Asia and Australia.
3. Capex Plans: The company has invested INR 2,700 crores in the last two years and plans a capex of INR 2,050 crores for FY '27 to support growth initiatives.
4. Dividend Increase: Proposed dividend for FY '26-'27 is INR 11 per share, up from INR 10 the previous year, indicating robust financial health.
5. High EBITDA and PAT: Q4 FY '26 reported EBITDA and PAT at INR 870 crores and INR 556 crores respectively, with full-year figures reaching INR 2,750 crores and INR 1,737 crores.

The focus on defense, international business, and operational efficiencies is expected to drive significant growth despite challenges in domestic mining markets.

Given the constraints of the task, here's a concise representation of major questions asked during the earnings call along with summaries of their respective answers:

Question 1: "What are the key geographies for international business expansion, particularly regarding Zimbabwe?"

Answer: We have indeed seen substantial growth in our international business. Looking ahead, we are focusing on the African continent, specifically expanding in South Africa, Zambia, Tanzania, and Zimbabwe. In West Africa, we've initiated operations in Nigeria and Ghana, with plans for Sierra Leone. Additionally, we're expanding in Turkey and Kazakhstan. Southeast Asia markets like Thailand and Indonesia are also part of our growth strategy.

Question 2: "Can you provide updates on the Bhargavastra counter-drone system and the 155 mm shells developments?"

Answer: Bhargavastra is a strategic project, and we are nearing the completion of its development. We expect to finalize all trials within this calendar year. Regarding the 155 mm shells, we've begun supplying raw materials, and our coupling facility should be operational in a couple of quarters. We anticipate starting full supply of the 155 mm rounds shortly thereafter.

Question 3: "What are the expectations for geographic market share in the export region?"

Answer: It is challenging to quantify specific market shares due to fluctuating market dynamics. We expect volume growth to be around 10% annually, with value growth at approximately 15% in the international market. Given that our export business has grown from INR 400 crores in 2015 to over INR 3,800 crores, we are optimistic about continued growth, aiming for around 30% in FY '27.

Question 4: "Could you explain the reasoning behind the significant working capital changes in FY '26?"

Answer: Working capital days increased in FY '26 primarily due to higher inventory levels aimed at mitigating geopolitical risks and maintaining supply chain continuity. This strategic decision will better position us for the future and is expected to normalize in the next couple of quarters.

Question 5: "What is the order book breakdown between defense and non-defense sectors?"

Answer: Our total order book stands at INR 21,300 crores, with approximately INR 18,000 crores assigned to defense and INR 3,000 crores to non-defense. The largest orders include those for the Pinaka system, with ongoing negotiations for additional contracts.

This summarizes the core questions and responses while respecting the limit on character count for each answer.